# A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician’s choice of treatment in patients with triple-class exposed/refractory multiple myeloma

> Research article (Current Medical Research and Opinion, 2023) · cited 12× · AI/ML

**Wikidata**: [openalex:W4389573292](https://www.wikidata.org/wiki/openalex:W4389573292)  
**Source**: https://4ort.xyz/entity/a-matching-adjusted-indirect-comparison-of-the-efficacy-of-elranatamab-versus-physicians-choice-of-treatment-in-patients